Biofrontera (BFRI) Income from Continuing Operations (2020 - 2025)

Biofrontera's Income from Continuing Operations history runs 6 years deep, the most recent figure standing at 5640000.0 for Q4 2025.

• In Q4 2025, Income from Continuing Operations rose 504.01% year-over-year to 5640000.0; the TTM figure through Dec 2025 stood at 10536000.0 (up 40.67% YoY), while the FY2025 annual figure was 10536000.0, up 40.67% from the prior year.
• Income from Continuing Operations was 5640000.0 for Q4 2025 at Biofrontera, up from 6649000.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 5640000.0 in Q4 2025 to a low of 16012000.0 in Q3 2021.
• Historically, Income from Continuing Operations has averaged 4338900.0 across 5 years, with a median of 3932000.0 in 2021.
• The sharpest annual moves came in 2021 and 2025: Income from Continuing Operations tumbled 7698.39% in 2021, then jumped 504.01% in 2025.
• A 5-year view of Income from Continuing Operations shows it stood at 14505000.0 in 2021, then soared by 80.8% to 2785000.0 in 2022, then jumped by 226.61% to 3526000.0 in 2023, then slumped by 139.59% to 1396000.0 in 2024, then surged by 504.01% to 5640000.0 in 2025.
• The last three Income from Continuing Operations figures came in at 5640000.0 (Q4 2025), 6649000.0 (Q3 2025), and 5324000.0 (Q2 2025), per Business Quant data.